The magnitude of sinus cycle length change during ventricular tachycardia is predictive of successful antitachycardia pacing

PACE - Pacing and Clinical Electrophysiology

Volumn 29, Issue 11, 2006, Pages 1195-1200

  Macgregor, John F ^a   Wasmund, Stephen L ^a   Pai, Rakesh K ^a   Abedin, Moeen ^a   Akoum, Nazem ^a   Segerson, Nathan M ^a   Freedman, Roger A ^a   Klein, Richard C ^a   Wall, T Scott ^a   Rawling, David A ^a   Shen, Shuying ^a   Hamdan, Mohamed H ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Defibrillation ICD; Noninvasive risk assessment tests; Pacing

Indexed keywords

CALCULATION; CONTROLLED STUDY; DEFIBRILLATOR; DIAGNOSTIC ACCURACY; HEART PACING; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; RETROSPECTIVE STUDY; REVIEW; STUDENT T TEST;

CARDIAC PACING, ARTIFICIAL; DIAGNOSIS, COMPUTER-ASSISTED; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; UTAH;

EID: 33750687267     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2006.00522.x     Document Type: Review

References (12)

1. Singh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W, Rushkin JN, et al. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: Findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol 2005; 46:1712-1720.
2. Weber M, Block M, Bansch D, Castrucci M, Gradaus R, Schriever C, Breithardt G, et al. Antitachycardia pacing for rapid VT during ICD charging: A method to prevent ICD shocks. Pacing Clin Electrophysiol 2001; 24:345-351.
3. Hamdan MH, Joglar JA, Page RL, Zagrodzky JD, Sheehan CJ, Wasmund SL, Smith ML. Baroreflex gain predicts blood pressure recovery during simulated ventricular tachycardia in humans. Circulation 1999; 100:381-386.
4. Kowal RC, Wasmund SL, Smith ML, Page RL, Joglar JA, Hamdan MH. Poor baroreflex gain is a marker of heightened sympathetic activity post-tachycardia termination in humans. Clin Auton Res 2003; 13:443-446.
5. Stata Release 9 Longitudinal/Panel Data Manual. College Station, Stata Press, 2005.
6. Schaumann A, von zur Muhlen F, Herse B, Gonska BD, Kreuzer H. Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: A prospective study including 200 patients. Circulation 1998; 97:66-74.
7. Newman D, Dorian P, Hardy J. Randomized controlled comparison of antitachycardia pacing algorithms for termination of ventricular tachycardia. J Am Coll Cardiol 1993; 21:1413-1418.
8. Gillis AM, Leitch JW, Sheldon RS, Morillo CA, Wyse DG, Yee R, Klein GJ, et al.Aprospective randomized comparison of autodecremental pacing to burst pacing in device therapy for chronic ventricular tachycardia secondary to coronary artery disease. Am J Cardiol 1993; 72:1146-1151.
9. Sweeney MO. Antitachycardia pacing for ventricular tachycardia using implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2004; 27:1292-1305.
10. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004; 110:2591-2596.
11. Peters RW, Zhang X, Gold MR. Clinical predictors and efficacy of antitachycardia pacing in patients with implantable cardioverter defibrillators: The importance of the patient's sex. Pacing Clin Electrophysiol 2001; 24:70-74.
12. Kouakam C, Lauwerier B, Klug D, Jarwe M, Marquie C, Lacroix D, Kacet S. Effect of elevated heart rate preceding the onset of ventricular tachycardia on antitachycardia pacing effectiveness in patients with implantable cardioverter defibrillators. Am J Cardiol 2003; 92:26-32.